26(top 1%)
papers
985(top 1%)
citations
16(top 1%)
h-index
24(top 1%)
g-index
27
all documents
1.0K
doc citations
436
citing journals

Top Articles

#TitleJournalYearCitations
1Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cellsBlood2007283
2Application of a Time-Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its ComponentsVox Sanguinis1999117
3Intermittent Exposure of Primitive Quiescent Chronic Myeloid Leukemia Cells to Granulocyte-Colony Stimulating Factor In vitro Promotes their Elimination by Imatinib MesylateClinical Cancer Research200686
4Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020Eurosurveillance202064
5Fibrin sealant reduces suture line bleeding during carotid endarterectomy: A randomised trialEuropean Journal of Vascular and Endovascular Surgery199555
6Expansion of Foxp3+ T‐cell populations by Candida albicans enhances both Th17‐cell responses and fungal dissemination after intravenous challengeEuropean Journal of Immunology201455
7In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or IbBritish Journal of Haematology200145
8Prion protein and developments in its detectionTransfusion Medicine200142
9Application of a Time–Resolved Fluoroimmunoassay for the Analysis of Normal Prion Protein in Human Blood and Its ComponentsVox Sanguinis199938
10Identification, immunomodulatory activity, and immunogenicity of the major helper T-cell epitope on the K blood group antigenBlood201233
11Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liverScientific Reports201729
12THE IMPACT OF NEW-VARIANT CREUTZFELDT-JAKOB DISEASE ON BLOOD TRANSFUSION PRACTICEBritish Journal of Haematology199925
13Hepatitis B virus genotypes and precore mutations in Scottish blood donorsVox Sanguinis200525
14Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19Frontiers in Immunology202025
15Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronavirusesJCI Insight202224
16Development of multiplexed nucleic acid testing for human immunodeficiency virus type 1 and hepatitis C virusVox Sanguinis200117
17Seroprevalence of lyme borreliosis in Scottish blood donorsTransfusion Medicine201517
18Species differences in the blood content of the normal cellular isoform of prion protein, PrPc , measured by time-resolved fluoroimmunoassayVox Sanguinis200116
19Detection of HTLV-I and -II in Scottish blood donor samples and archive donationsVox Sanguinis200616
20Automatically Controlled Continuous Recovery of Plasma Protein Fractions for Clinical Use: A Preliminary ReportVox Sanguinis197010
21A report: “Reagents for the 1990’s”Immunohematology19918
22Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel diseaseGut20223
23First HIV ‘window period’ donation in a UK blood donorTransfusion Medicine20052
24Human immunodeficiency virus 1 subtypes detected in Scottish blood donorsVox Sanguinis20092
25BLOOD FRACTIONSLancet, The19540
26Does the Storage Time of Transfused Red Blood Cells Influence Critically Ill Patients?: The authors replyCritical Care Medicine20040